MYTILINEOS ENERGY & METALS: FIRST QUARTER 2024 TRADING UPDATE (3)
MYTILINEOS' growth trajectory enhanced by the synergies between Energy and Metallurgy
Stay updated with breaking news from Before Interest. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
MYTILINEOS' growth trajectory enhanced by the synergies between Energy and Metallurgy
Pharma firm Laurus Labs reported a 25 percent fall in net profit for the March 2024 quarter. Net profit slipped to Rs 76 crore in the March 2024 quarter from Rs 102 crore in the year-ago period. The results were announced during market hours. The stock slipped up to 3.26% to Rs 420.20 after the earnings. Later, it closed 2.09% lower at Rs 425.30 on BSE. Revenue climbed 4 percent to Rs 1,439.67 crore in the last quarter from Rs 1,380.90 crore in the year ago period.
Indiva Remains the National Market Share Leader in the Edibles Category and Ranks #2 Nationally in Unit Share Across All Cannabis Categories ...
FORT WORTH, Texas, April 25, 2024 (GLOBE NEWSWIRE) -- FirstCash Holdings, Inc. (“FirstCash” or the “Company”) (Nasdaq: FCFS), the leading international...
MYTILINEOS' growth trajectory enhanced by the synergies between Energy and Metallurgy